Immucell (ICCC) Share-based Compensation (2010 - 2026)
Immucell's Share-based Compensation was $103,781 in Q4 2025, up 50.7% from $68,863 a year earlier and up 41.9% from the prior quarter.
Powered by 
Analysis
Immucell (ICCC) Share-based Compensation (2010 - 2026) Analysis & Trends
For FY2025, Share-based Compensation at Immucell came in at $295,871, down 9.1% from FY2024.
- Share-based Compensation shows a five-year compound annual growth rate of 3.2% (FY2020 to FY2025).
- In earlier years, Share-based Compensation was $325,551 in FY2024 (-11.7%), $368,866 in FY2023 (+38.5%), $266,244 in FY2022 (+84.5%) and $144,313 in FY2021 (-43.0%).
- The Q4 2025 figure marks the highest quarterly Share-based Compensation in data going back to Q3 2010.
- Compared with a year earlier, Share-based Compensation was higher in two of the last eight quarters, with an average decline of 7.5%.
- The best year-over-year quarter for Share-based Compensation over five years was Q2 2022 (growth of 164.9%); the worst was Q2 2021 (a decline of 58.9%).
- Per Business Quant data, ICCC's Share-based Compensation in the three quarters before Q4 2025 was $73,161 (Q3 2025), $66,714 (Q2 2025) and $52,215 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.43 Bn | 1,102.02 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 615.31 Bn | 533.83 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 505.93 Bn | 479.05 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 297.69 Bn | 261.68 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.59 Bn | 235.28 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.28 Bn | 191.68 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 190.31 Bn | 164.51 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 170.69 Bn | 117.33 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Immucell | 95.18 Mn | 72.63 Mn | 2.44 Mn | 239,867.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 239,867.00 |
| Dec 31, 2025 | 103,781.00 |
| Sep 30, 2025 | 73,161.00 |
| Jun 30, 2025 | 66,714.00 |
| Mar 31, 2025 | 52,215.00 |
| Dec 31, 2024 | 68,863.00 |
| Sep 30, 2024 | 77,557.00 |
| Jun 30, 2024 | 98,021.00 |
| Mar 31, 2024 | 81,110.00 |
| Dec 31, 2023 | 100,659.00 |
| Sep 30, 2023 | 96,434.00 |
| Jun 30, 2023 | 75,657.00 |
| Mar 31, 2023 | 96,116.00 |
| Dec 31, 2022 | 65,395.00 |
| Sep 30, 2022 | 85,122.00 |
| Jun 30, 2022 | 61,635.00 |
| Mar 31, 2022 | 54,093.00 |
| Dec 31, 2021 | 40,931.00 |
| Sep 30, 2021 | 45,488.00 |
| Jun 30, 2021 | 23,265.00 |
API Access
Immucell Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();